Effects of rhG-CSF on neutrophil functions and bone marrow parameters in diabetic rats

Endocrine Research

Volumn 25, Issue 3-4, 1999, Pages 381-395

  Cantürk, Zeynep ^a,c   Cantürk, Nuh Zafer ^a   Çetinarslan, Berrin ^a   Erçin, Cengiz ^a   Dökmetaş, Sebila ^b   Şencan, Mehmet ^b  

^a KOCAELI UNIVERSITY   (Turkey)

^b CUMHURIYET UNIVERSITY   (Turkey)

^c Canan Sk Asim Bey Ap   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BONE MARROW CELL; CELL FUNCTION; CELL HYPERPLASIA; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HOST RESISTANCE; NEUTROPHIL; NEUTROPHILIA; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0345072578     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1080/07435809909066155     Document Type: Article

References (35)

1. th ed., Lea&Febiger, Pennsylvania. pp.868-882.
2. Larkin JG, Frier BM, Ireland JT. 1985 Diabetes mellitus and infection. Postgraduate Med J 61:233-237.
3. Sato N, Shimizu H. 1993 Granulocyte-colony stimulating factor improves an impaired bactericidal function in neutrophils from STZ-induced diabetic rats. Diabetes Care 42:470-473.
4. Langmuir PB, Bridgett MM, Bothwell AL, Crispe IN Bone marrow abnormalities in the non-obese diabetic mouse. Int Immunol 1993; 5(2):169-77.
5. Cantürk Z, Cantürk NZ, Önen F: Effects of rhG-CSF on neutrophil functions and survival in sepsis induced diabetic rats. Endocr Res, 24(2): 141-157, 1998.
6. Canturk NZ, Vural B, Esen N, et al. Effects of granulocyte-macrophage colony-stimulating factor on incisional wound healing of experimental diabetic rat model. Endocr Res 1999; 25:105-116.
7. Brandt L. 1965 Adhesiveness to glass and phagocytic activity of neutrophilic leukocytes in myeloproliferative diseases. Scand J Haematol 2: 126-129.
8. Penny R, Galton DA, Scott JT, Eisen V. 1966 Studies on neutrophil function I: Physiological and pharmacological aspects. Br J Haematol 12: 623-632.
9. Chervenick, P.A., Boggs, D.R., Marsh, J.C., et al. 1968 Quantitative studies of blood and bone marrow neutrophils in normal mice. Am. J. Physiol. 215:353.
10. Hulse, E.V. 1964 Quantitative cell counts of the bone marrow and blood and their secular variations in the normal adult rat. Acta Haematol. 31:50,.
11. Cutler CW, Eke P, Arnold RR, Van Dyke TE. 1991 Defective neutrophil function in an insulin dependent diabetes mellitus patient. J Peridontol 2(6): 394-401.
12. th ed., Appleton&Lange; Lebanon, pp: 141-145.
13. Manouchehr-Pour M, Spagnuolo P, Rodman H, Bissada N. 1981 Impaired neutrophil chemotaxis in diabetic patients with severe peritonitis. J Dent Res 60:729-733.
14. Golub L, Nicoll G, Iacono V, Ramamurthy N. 1982 In vivo crevicular leukocyte response to a chemotactic challenge: Inhibition by experimental diabetes. Infect Immun 37:1013-1017.
15. Davidson J, Sowden JM, Fletcher J. 1984 Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonizing proteins . J Clin Pathol 37:783-790.
16. Marhoffer W, Stein M, Masser E, Federlin K. 1992 Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 15:256-260.
17. Alexiewicz JM, Kumar D, Smogorzewski M, Klin M, Massry SG. 1995 Polymorphonuclear Leukocytes in non-insulin -dependent diabetes mellitus: Abnormalities in metabolism and function. Ann Intern Med 123:919-924.
18. Bybee JD, Rogers DE. 1964 The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus. J Lab Clin Med 64: 1-13.
19. Drachman RH, Root RK, Wood WB.1966 Studies on the effect of experimental nonketotic diabetes mellitus on antibactericidal defense : Demonstration of a defect in phagocytosis. J Exp Med 124: 227-240.
20. Stickle JE, Tvedten HW, Schall WD, Smith CW. 1986 Adherence of neutrophils from dogs with diabetes mellitus. Am J Vet Res 47:541-543.
21. Blatmer KS, Mahaffey EA. 1984 Neutrophil adherence and movement in poorly and well controlled diabetic dogs. Am J Vet Res 45(8): 1498-1500.
22. Bagdade JD, Walters E. 1980 Impaired granulocyte adherence in mildly diabetic patients: effects of tolazamide treatment. Diabetes 29: 309-311.
23. Andersen B, Goldsmith GH, Spagnuolo PJ. 1980 Neutrophil adhesive dysfunction in diabetes mellitus: The role of cellular plasma factors. J Lab Clin Med 111: 275-285.
24. Selam, J.L., Clot, J., Andary, M., et al Circulating lymphocyte subpopulations in juvenile insulin-dependent diabetes. Diabetologia 16:35, 1979.
25. Naji, A., Hiromitsu, K., Silvers, W.K., et al. Numerical and functional abnormality of T suppressor cells in diabetic rats. Surgery, 94:235, 1983.
26. Nicholas, W.K., Vann, L.L. & Spellman, V.J. Streptozotocin effects on T Lymphocytes and bone marrow cells. Clin. Exp. Immunol. 46:677, 1981.
27. Ishibahi, T., Kitahara, Y., Harada, Y., et al. Immunologic features of mice with streptozotocin-induced diabetes: depression of their immune responses to sheep red blood cells. Diabetes 29:516, 1980.
28. Iguchi K, Inoue S, Kumar A. 1991 Effect of recombinant human granulocyte colony stimulating factor administration in normal and experimentally infected newborn rats. Exp Hematol 19: 352-358.
29. Silver GM, O'Reilly M, Mooney DP 1 . 1989 The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival following Pseudomonas burn wound infection. Surgery 106: 452-455.
30. Lindemann A, Herrmann F, Oster W, Haffner G, Meyenburg W, Souza LM, Mertelsmann R. 1989 Hematologic effects of recombinant human granulocyte colon-stimulating factor in patients with malignancy. Blood 74(8): 2644-2651.
31. Roilides E, Walsh TJJ, Pizzo PA, Rubin M. 1991 Granulocyte colony stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Inf Dis 163: 579-583.
32. Cohen, A.M., Zsebo, K., Inoue, H., et al. In vivo stimulation of granulopoiesis by recombinant human granulocyte colony stimulating factor. Proc. Natl. Acad. Sci. USA 84:2484, 1987.
33. Welte, K., Bonilla, M.A., Gillio, A.P., et al. Recombinant human granulocyte colony stimulating factor: effects of hematopoiesis in normal and cyclophosphamide-treated primates. J. Exp. Med. 165:941,1987.
34. Ulich; T.R., Castillo, J.D. & Souza, L. Kinetics and mechanisms of recombinant human granulocyte-colony stimulating factor-induced neutrophilia. Am. J. Pathol. 133:630, 1988.
35. Sato N, Shimuzu H, Shimomura Y, Uehara Y, Takahshi M, Kobayashi I. 1992 Reduced ability of neutrophils to produce active oxygen species in strepzotocin-induced diabetic rats. Exp Clin Endocrinol 9:31-33.